Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure: The STOP-HF Randomized Trial

Study Questions:

What is the impact of a brain-type natriuretic peptide (BNP)-based screening and intervention initiative on the prevalence of left ventricular (LV) dysfunction with or without newly diagnosed heart failure (HF) in an at-risk population?